Do you have the same question? Follow this Question
Jan 08, 2026 - 09:17 AM
We’ve provided several answers to questions related to Tarpeyo (Budesonide) , see some other helpful Q&A related to this product.
Question: What is the PubChem CID for budesonide?
Answer: The PubChem CID is 5281004. PubChem provides comprehensive chemical information, which can be useful for healthcare professionals and researchers.
Question: What is in the printing ink on the capsules?
Answer: The printing ink includes shellac, propylene glycol, and black iron oxide (E172). These ingredients are used for labeling and identification, which helps ensure you are taking the correct medication.
Question: What is the route of administration for this medication?
Answer: The primary route is oral, but budesonide can also be administered by inhalation, intranasal, and rectal routes. Different routes allow the medication to be used for various conditions, enhancing its versatility.
Question: What is the elimination half-life of this medication?
Answer: The elimination half-life is 2–3.6 hours. The half-life refers to the time it takes for half of the drug to be eliminated from the body, which can impact dosing schedules and how long the drug stays effective.
Question: What form does this medication come in?
Answer: This medication comes in delayed release oral capsules. Delayed release means the capsule is designed to pass through the stomach and dissolve in the intestine, which can help reduce stomach irritation and improve how the medication works.
